======= NIT2 =======
== Gene Information ==
* **Official Symbol**: NIT2
* **Official Name**: nitrilase family member 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56954|56954]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQR4|Q9NQR4]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NIT2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NIT2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616769|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Has a omega-amidase activity. The role of omega-amidase is to remove potentially toxic intermediates by converting alpha- ketoglutaramate and alpha-ketosuccinamate to biologically useful alpha-ketoglutarate and oxaloacetate, respectively. Overexpression decreases the colony-forming capacity of cultured cells by arresting cells in the G2 phase of the cell cycle. {ECO:0000269|PubMed:17488281, ECO:0000269|PubMed:19595734}.
|CN hydrolase|
|omega-amidase activity|
|asparagine metabolic process|
|oxaloacetate metabolic process|
|glutamine metabolic process|
|aspartate family amino acid metabolic process|
|tertiary granule lumen|
|specific granule lumen|
|glutamine family amino acid metabolic process|
|dicarboxylic acid metabolic process|
|alpha-amino acid metabolic process|
|cellular amino acid metabolic process|
|neutrophil degranulation|
|centrosome|
|neutrophil activation involved in immune response|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|monocarboxylic acid metabolic process|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|regulated exocytosis|
|leukocyte mediated immunity|
|cellular amide metabolic process|
|exocytosis|
|carboxylic acid metabolic process|
|leukocyte activation|
|oxoacid metabolic process|
|secretion by cell|
|organic acid metabolic process|
|export from cell|
|cell activation|
|immune effector process|
|secretion|
|small molecule metabolic process|
|immune response|
|extracellular region|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.77|
|[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|7.77|
^Gene^Correlation^
|[[:human genes:p:polr2j3|POLR2J3]]|0.47|
|[[:human genes:h:hif1a|HIF1A]]|0.419|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16561
* **Expression level (log2 read counts)**: 5.87
{{:chemogenomics:nalm6 dist.png?nolink |}}